Eclipse Equinox p2 inclusion of functionality from untrusted control sphere
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 8.1 | $0-$5k | 0.00 |
Summary
A vulnerability was found in Eclipse Equinox p2. It has been declared as critical. Impacted is an unknown function. Such manipulation leads to inclusion of functionality from untrusted control sphere. This vulnerability is traded as CVE-2021-41037. The attack may be launched remotely. There is no exploit available.
Details
A vulnerability, which was classified as critical, has been found in Eclipse Equinox p2 (version now known). Affected by this issue is some unknown processing. The manipulation with an unknown input leads to a inclusion of functionality from untrusted control sphere vulnerability. Using CWE to declare the problem leads to CWE-829. The product imports, requires, or includes executable functionality (such as a library) from a source that is outside of the intended control sphere. Impacted is confidentiality, integrity, and availability. CVE summarizes:
In Eclipse p2, installable units are able to alter the Eclipse Platform installation and the local machine via touchpoints during installation. Those touchpoints can, for example, alter the command-line used to start the application, injecting things like agent or other settings that usually require particular attention in term of security. Although p2 has built-in strategies to ensure artifacts are signed and then to help establish trust, there is no such strategy for the metadata part that does configure such touchpoints. As a result, it's possible to install a unit that will run malicious code during installation without user receiving any warning about this installation step being risky when coming from untrusted source.
The weakness was shared 07/08/2022. The advisory is shared for download at bugs.eclipse.org. This vulnerability is handled as CVE-2021-41037 since 09/13/2021. There are neither technical details nor an exploit publicly available.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Vendor
Name
License
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 8.1VulDB Meta Temp Score: 8.1
VulDB Base Score: 6.3
VulDB Temp Score: 6.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 8.0
NVD Vector: 🔍
CNA Base Score: 10.0
CNA Vector (Eclipse Foundation): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Inclusion of functionality from untrusted control sphereCWE: CWE-829
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
09/13/2021 🔍07/08/2022 🔍
07/08/2022 🔍
07/12/2024 🔍
Sources
Advisory: bugs.eclipse.orgStatus: Confirmed
CVE: CVE-2021-41037 (🔍)
GCVE (CVE): GCVE-0-2021-41037
GCVE (VulDB): GCVE-100-203384
Entry
Created: 07/08/2022 09:05Updated: 07/12/2024 17:38
Changes: 07/08/2022 09:05 (46), 07/20/2022 10:51 (18), 07/12/2024 17:38 (25)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.